The Effects of a Fatty Acid Synthase Inhibitor on Multi-drug Resistant Ovarian Cancer Cells
CSEF · 2008 Pharmacology/ Toxicology Fourth Award
Overview
Objectives/Goals The objective is to determine the effect of a fatty acid synthase inhibitor on multi-drug resistant ovarian cancer cells compared to drug sensitive ovarian cancer cells. Hypothesis: Multi-drug resistance reduces the endoplasmic reticulum stress response in ovarian cancer cells after treatment with Orlistat. Methods/Materials Cell viability was tested with the drug Orlistat to both the drug resistant and drug sensitive cancer cells with a trypan blue exclusion. The SRB assay was then conducted to compare cell viability after treatment with Orlistat. Finally a Coomassie stain was conducted to qualitatively assess the proteins in both ovarian cancer cell lines before and after Orlistat treatment. Results Treatment of ovarian cancer cells with Orlistat dramatically reduces cell proliferation as determined by the trypan blue exclusion assay. After a 72 hr orlistat treatment, the multi-drug resistant ovarian cancer cells, NCI/ADR, showed growth recovery, while the sensitive cells, OVCAR-8 continued to decline. Conclusions/Discussion As shown by the trypan blue exclusion and the SRB assay, there was resistance to Orlistat in the multi-drug resistant ovarian cancer cells. The Coomassie stained gel showed obvious differences in protein profiles between the two cell lines and between the treated and untreated cells. A Dual-Luciferase Reporter Assay will be performed with a DNA plasmid that responds to endoplasmic reticulum stress (GRP78-Luc). This will be compared to a control plasmid (pGL3) and a standard unit our internal control (Renilla plasmid) by measuring the amount of luminescence in a luminometer. The plasmids will be transfected into the both drug resistant and drug sensitive ovarian cancer cells. The luciferase reporter would be able to compare GRP78, which will show endoplasmic reticulum stress, activity between drug resistant and drug sensitive cells after Orlistat treatment.
Summary statement
To determine the effect of a fatty acid synthase inhibitor (Orlistat) on multi-drug resistant ovarian cancer cells compared to drug sensitive ovarian cancer cells through several approaches.
Help received
Jason Bush PhD, California State University Fresno
Awards (1)
Competition history
- CSEF 2008
Resources
Related projects
CSEF · 2009
Mechanisms of Survival Against a Fatty Acid Synthase Inhibitor in Multidrug Resistant Ovarian Cancer
CSEF · 2010
Multi-Drug Resistance and the Mechanism of Orlistat-Induced Cell Death in Ovarian Carcinoma
CSEF · 2012
Investigating the Inhibitory Effect of Resveratrol on Ovarian Cancer Cells
ISEF · 2018
New Potential Therapy for Ovarian Cancer: Stearoyl-CoA Desaturase-1 (SCD1) Inhibition with the Novel Compound SSI-4
CSEF · 2018
Identifying the Mechanisms of Liver Cancer Cell Drug Resistance
ISEF · 2020
Examining Mechanisms of Resistance in Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells
CSEF · 2016
Investigation of Glucocorticoid Receptor Degradation and Its Antagonists to Address Cancer Drug Resistance
ISEF · 2023
The Effects of APC Loss on Response to Chemotherapy in Ovarian Cancer Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects